179
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

In silico screening of FDA approved drugs against ACE2 receptor: potential therapeutics to inhibit the entry of SARS-CoV-2 to human cells

, , , &
Pages 11383-11394 | Received 23 Nov 2020, Accepted 15 Jul 2021, Published online: 28 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sunil Kumar Patnaik, Selvaraj Ayyamperumal, Dhananjay Jade, Nagarjuna Palathoti, Krishna Swaroop Akey, Srikanth Jupudi, Michael A. Harrison, Sreenivasan Ponnambalam, Nanjan MJ & Chandrasekar MJN. (2023) Virtual high throughput screening of natural peptides against ErbB1 and ErbB2 to identify potential inhibitors for cancer chemotherapy. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-24.
Read now

Articles from other publishers (1)

Davide Pirolli, Benedetta Righino, Chiara Camponeschi, Francesco Ria, Gabriele Di Sante & Maria Cristina De Rosa. (2023) Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface. Scientific Reports 13:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.